Display options
Share it on

Neuropsychiatr Dis Treat. 2014 Nov 14;10:2191-200. doi: 10.2147/NDT.S60854. eCollection 2014.

Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures.

Neuropsychiatric disease and treatment

Joanna H Cox, Stefano Seri, Andrea E Cavanna

Affiliations

  1. College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  2. School of Life and Health Sciences, Aston Brain Centre, Aston University, Birmingham, UK ; Children's Epilepsy Surgery Programme, The Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK.
  3. College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK ; School of Life and Health Sciences, Aston Brain Centre, Aston University, Birmingham, UK ; Department of Neuropsychiatry, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK ; Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology and UCL, London, UK.

PMID: 25484587 PMCID: PMC4238748 DOI: 10.2147/NDT.S60854

Abstract

About one third of patients with epilepsy are refractory to medical treatment. For these patients, alternative treatment options include implantable neurostimulation devices such as vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive neurostimulation systems (RNS). We conducted a systematic literature review to assess the available evidence on the clinical efficacy of these devices in patients with refractory epilepsy across their lifespan. VNS has the largest evidence base, and numerous randomized controlled trials and open-label studies support its use in the treatment of refractory epilepsy. It was approved by the US Food and Drug Administration in 1997 for treatment of partial seizures, but has also shown significant benefit in the treatment of generalized seizures. Results in adult populations have been more encouraging than in pediatric populations, where more studies are required. VNS is considered a safe and well-tolerated treatment, and serious side effects are rare. DBS is a well-established treatment for several movement disorders, and has a small evidence base for treatment of refractory epilepsy. Stimulation of the anterior nucleus of the thalamus has shown the most encouraging results, where significant decreases in seizure frequency were reported. Other potential targets include the centromedian thalamic nucleus, hippocampus, cerebellum, and basal ganglia structures. Preliminary results on RNS, new-generation implantable neurostimulation devices which stimulate brain structures only when epileptic activity is detected, are encouraging. Overall, implantable neurostimulation devices appear to be a safe and beneficial treatment option for patients in whom medical treatment has failed to adequately control their epilepsy. Further large-scale randomized controlled trials are required to provide a sufficient evidence base for the inclusion of DBS and RNS in clinical guidelines.

Keywords: deep brain stimulation; epilepsy; implantable neurostimulation device; responsive neurostimulation; seizures; vagus nerve stimulation

References

  1. Behav Neurol. 2011;24(1):35-41 - PubMed
  2. Lancet Neurol. 2002 Dec;1(8):477-82 - PubMed
  3. Discov Med. 2010 Feb;9(45):138-44 - PubMed
  4. Nat Rev Neurosci. 2007 Aug;8(8):623-35 - PubMed
  5. Epilepsia. 2007 Aug;48(8):1561-71 - PubMed
  6. Neurosurg Focus. 2010 Aug;29(2):E8 - PubMed
  7. CNS Drugs. 2012 Apr 1;26(4):319-35 - PubMed
  8. Epilepsia. 2007 Oct;48(10):1895-903 - PubMed
  9. Seizure. 2009 Oct;18(8):588-92 - PubMed
  10. Neurology. 2006 May 23;66(10):1490-4 - PubMed
  11. Acta Neurochir (Wien). 1976;(23 Suppl):257-62 - PubMed
  12. Epilepsia. 2005 Jul;46(7):1071-81 - PubMed
  13. Neurosurgery. 2008 Feb;62 Suppl 2:506-13 - PubMed
  14. Neurol Clin. 2009 Nov;27(4):1003-13 - PubMed
  15. Epilepsia. 2002 Jun;43(6):603-8 - PubMed
  16. Seizure. 2011 Jul;20(6):485-90 - PubMed
  17. Pediatr Neurol. 2006 Nov;35(5):323-6 - PubMed
  18. Epilepsia. 2006 Jul;47(7):1203-12 - PubMed
  19. Epilepsia. 2001 Sep;42(9):1148-52 - PubMed
  20. Epilepsia. 2013 Oct;54(10):1823-33 - PubMed
  21. Neurol Res. 2000 Apr;22(3):247-58 - PubMed
  22. Epilepsia. 2010 Feb;51(2):304-7 - PubMed
  23. Ann Neurol. 2002 Nov;52(5):556-65 - PubMed
  24. JAMA Neurol. 2013 Feb;70(2):163-71 - PubMed
  25. Trans Am Neurol Assoc. 1973;98:192-6 - PubMed
  26. Ann Pharmacother. 2012 Feb;46(2):248-54 - PubMed
  27. Epilepsia. 2014 Apr;55(4):475-82 - PubMed
  28. Int J Neural Syst. 2013 Feb;23(1):1250034 - PubMed
  29. Epilepsia. 2007 Aug;48(8):1551-60 - PubMed
  30. Ann Neurol. 2005 Feb;57(2):258-68 - PubMed
  31. J Clin Neurophysiol. 2004 Jul-Aug;21(4):283-9 - PubMed
  32. J Cent Nerv Syst Dis. 2012 Jun 19;4:105-15 - PubMed
  33. Clin Neurol Neurosurg. 2004 Sep;106(4):318-29 - PubMed
  34. Seizure. 2012 Apr;21(3):183-7 - PubMed
  35. Behav Neurol. 2011;24(1):43-6 - PubMed
  36. Acta Neurochir Suppl. 2006;99:87-91 - PubMed
  37. Neurosurgery. 2000 Aug;47(2):295-304; discussion 304-5 - PubMed
  38. Curr Behav Neurosci Rep. 2014 Jun;1(2):64-73 - PubMed
  39. Ther Adv Neurol Disord. 2011 Nov;4(6):385-407 - PubMed
  40. Seizure. 2014 Jan;23(1):6-9 - PubMed
  41. Epilepsia. 2000 Sep;41(9):1195-200 - PubMed
  42. Neurosurg Focus. 2012 Mar;32(3):E13 - PubMed
  43. Chin Med J (Engl). 2013;126(17):3364-70 - PubMed
  44. Epilepsy Behav. 2013 Nov;29(2):416-9 - PubMed
  45. Neurology. 2011 Sep 27;77(13):1295-304 - PubMed
  46. Stereotact Funct Neurosurg. 2010;88(5):281-7 - PubMed
  47. Epilepsia. 1995 Jan;36(1):63-71 - PubMed
  48. Seizure. 2004 Apr;13(3):176-8 - PubMed
  49. J Neurol Neurosurg Psychiatry. 1984 Aug;47(8):769-74 - PubMed
  50. Pediatr Int. 2001 Feb;43(1):61-5 - PubMed
  51. Mov Disord. 2008 Nov 15;23(15):2111-21 - PubMed
  52. Stereotact Funct Neurosurg. 2012;90(6):379-85 - PubMed
  53. Arch Neurol. 1976 Aug;33(8):559-70 - PubMed
  54. Eur J Paediatr Neurol. 2007 Sep;11(5):261-9 - PubMed
  55. Seizure. 2013 Jun;22(5):390-5 - PubMed
  56. Isr Med Assoc J. 2013 Nov;15(11):673-7 - PubMed
  57. Stereotact Funct Neurosurg. 2001;77(1-4):228-32 - PubMed
  58. Neuromodulation. 2013 Nov-Dec;16(6):551-6; discussion 556 - PubMed
  59. Epilepsia. 1992 Sep-Oct;33(5):841-51 - PubMed
  60. Dev Med Child Neurol. 2012 Sep;54(9):855-61 - PubMed
  61. Epileptic Disord. 2002 Dec;4 Suppl 3:S83-93 - PubMed
  62. Neurosurgery. 1977 Sep-Oct;1(2):203-5 - PubMed
  63. Epilepsia. 2011 Jun;52(6):1052-7 - PubMed
  64. Epilepsy Behav. 2011 Jan;20(1):57-63 - PubMed
  65. Seizure. 2011 May;20(4):331-5 - PubMed
  66. Epilepsy Behav. 2011 Mar;20(3):478-83 - PubMed
  67. Brain Res Bull. 2013 Aug;97:39-47 - PubMed
  68. Epilepsy Res. 2012 Feb;98(2-3):135-9 - PubMed
  69. Epilepsia. 2006 Jul;47(7):1239-41 - PubMed
  70. Epilepsia. 2011 Jun;52(6):1058-62 - PubMed
  71. Lancet Neurol. 2012 Sep;11(9):814-26 - PubMed
  72. Front Syst Neurosci. 2014 Mar 14;8:33 - PubMed
  73. Epilepsia. 2004 Apr;45(4):346-54 - PubMed
  74. Neurology. 1999 Nov 10;53(8):1731-5 - PubMed
  75. Epilepsia. 2009 Dec;50(12):2671-2 - PubMed
  76. Stereotact Funct Neurosurg. 1997;69(1-4 Pt 2):221-4 - PubMed
  77. Epilepsia. 2010 May;51(5):899-908 - PubMed
  78. Neurology. 1995 Feb;45(2):224-30 - PubMed
  79. Nat Rev Neurol. 2009 May;5(5):267-76 - PubMed
  80. Pediatr Neurol. 2001 Sep;25(3):213-6 - PubMed
  81. Epilepsia. 2005;46 Suppl 5:98-9 - PubMed
  82. Acta Neurochir (Wien). 2010 Dec;152(12):2053-62 - PubMed
  83. Neurology. 2002 Nov 12;59(9):1421-4 - PubMed
  84. Stereotact Funct Neurosurg. 1990;54-55:56-9 - PubMed
  85. Neurosurg Focus. 2008 Sep;25(3):E12 - PubMed
  86. Br J Neurosurg. 2011 Feb;25(1):38-44 - PubMed
  87. Electroencephalogr Clin Neurophysiol Suppl. 1978;(34):349-54 - PubMed
  88. J Clin Psychopharmacol. 2012 Jun;32(3):362-75 - PubMed
  89. Epilepsy Behav. 2014 Jan;30:38-42 - PubMed
  90. Neurology. 2012 May 15;78(20):1548-54 - PubMed
  91. Lancet Neurol. 2012 Jan;11(1):5-7 - PubMed
  92. Epilepsia. 2007 Feb;48(2):342-7 - PubMed
  93. Seizure. 2010 Jun;19(5):264-8 - PubMed
  94. Neurology. 1998 Jul;51(1):48-55 - PubMed

Publication Types